Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR Cancers
Clinical trial NCT07542262 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07542262
- Sponsor
- Blokhin's Russian Cancer Research Center
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-03
- Primary completion
- 2028-03-30
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.